Sr. Scientist I, Analytical Sciences
BioMarin Pharmaceutical Inc.
Summary
The Analytical Sciences team within Technical Development Services is seeking a Sr. Scientist I to support analytical development activities across BioMarin's pipeline, with a primary focus on synthetic molecules, including small molecules, peptides, and oligonucleotides. The successful candidate will support the development, qualification, transfer, and lifecycle management of analytical methods. The role requires expertise in LC-MS, U/HPLC, and a variety of analytical characterization techniques, including NMR, DSC, XRPD, and dissolution testing. These methods will support synthetic drug characterization, control strategy development, comparability assessments, process development, formulation development, and regulatory submissions. The ideal candidate is a highly motivated and adaptable scientist with strong expertise in synthetic drug analytical development and control strategies. Success in this role requires excellent communication, collaboration, and problem-solving skills, as well as the ability to work effectively with cross-functional teams including Analytical Sciences, Process Development, Formulation Development, Quality, Regulatory Affairs, and Research.
Job description
Summary
The Analytical Sciences team within Technical Development Services is seeking a Sr. Scientist I to support analytical development activities across BioMarin's pipeline, with a primary focus on synthetic molecules, including small molecules, peptides, and oligonucleotides. The successful candidate will support the development, qualification, transfer, and lifecycle management of analytical methods. The role requires expertise in LC-MS, U/HPLC, and a variety of analytical characterization techniques, including NMR, DSC, XRPD, and dissolution testing. These methods will support synthetic drug characterization, control strategy development, comparability assessments, process development, formulation development, and regulatory submissions. The ideal candidate is a highly motivated and adaptable scientist with strong expertise in synthetic drug analytical development and control strategies. Success in this role requires excellent communication, collaboration, and problem-solving skills, as well as the ability to work effectively with cross-functional teams including Analytical Sciences, Process Development, Formulation Development, Quality, Regulatory Affairs, and Research.
Responsibilities
- Develop and optimize chromatography-, capillary-, spectroscopy-, and mass spectrometry-based analytical methods to support synthetic drug development, including small molecules, peptides, and oligonucleotides.
- Support analytical characterization, comparability assessments, process development, formulation development, and control strategy implementation.
- Prepare, review, and approve analytical protocols, technical reports, and scientific documentation.
- Author and review analytical sections of regulatory submissions and support responses to regulatory agency questions.
- Document experiments, data, and scientific findings in electronic laboratory systems in a manner suitable for regulatory inspection.
- Participate in laboratory operations, including instrument qualification, maintenance, and troubleshooting activities.
- Mentor junior scientists and research associates as needed.
- Collaborate with internal and external partners across Technical Development, Quality, Regulatory Affairs, and Research teams.
Required Qualifications
- Strong expertise in analytical development for synthetic molecules and analytical control strategy development.
- Hands-on experience with separation science and mass spectrometry, including LC-MS.
- Experience with chromatographic techniques, including: Size Exclusion Chromatography (SEC), Ion Exchange Chromatography (IEX), Reverse Phase Chromatography (RP), Hydrophilic Interaction Liquid Chromatography (HILIC).
- Experience with common detection technologies, including: UV, CAD, ELSD, FLD, MS.
- Ability to integrate data from multiple analytical platforms to solve complex characterization challenges.
- Experience developing and executing phase-appropriate analytical methods supporting: Drug Substance (DS), Drug Product (DP), Formulation Development, Process Characterization, Comparability Studies, Control Strategy Development.
- Working knowledge of USP, ICH, FDA, EMA, PMDA, and other global regulatory requirements.
- Strong scientific writing, presentation, and communication skills.
- Excellent critical thinking and problem-solving abilities.
- Proven ability to manage multiple priorities in a fast-paced environment and rapidly learn new technologies.
Preferred Qualifications
- Experience supporting late-stage analytical development activities, including: Phase III clinical development, Process Performance Qualification (PPQ), NDA filings, Commercial product support.
- Experience authoring, reviewing, or supporting regulatory submissions, including: INDs, MAAs, Responses to health authority questions.
- Broader analytical development experience across additional molecular modalities.
- Demonstrated ability to quickly learn new technologies and contribute across diverse analytical disciplines.
Education & Experience
Sr. Scientist I: PhD in Chemistry, Biochemistry, Pharmaceutical Chemistry, or a related scientific discipline with 5+ years of relevant post-graduate industry experience. OR Master's degree in Chemistry, Biochemistry, Pharmaceutical Chemistry, or a related scientific discipline with 10+ years of relevant post-graduate industry experience.
Location
Full-time onsite position in Novato, California. Travel: Minimal travel required (0-5%). Occasional travel may be necessary based on business needs.
Requirements
- Strong expertise in analytical development for synthetic molecules and analytical control strategy development.
- Hands-on experience with separation science and mass spectrometry, including LC-MS.
- Experience with chromatographic techniques, including SEC, IEX, RP, HILIC.
- Experience with common detection technologies, including UV, CAD, ELSD, FLD, MS.
- Ability to integrate data from multiple analytical platforms to solve complex characterization challenges.
- Experience developing and executing phase-appropriate analytical methods supporting DS, DP, formulation development, process characterization, comparability studies, and control strategy development.
- Working knowledge of USP, ICH, FDA, EMA, PMDA, and other global regulatory requirements.
- Strong scientific writing, presentation, and communication skills.
- Excellent critical thinking and problem-solving abilities.
- Proven ability to manage multiple priorities in a fast-paced environment and rapidly learn new technologies.
- PhD in Chemistry, Biochemistry, Pharmaceutical Chemistry, or a related scientific discipline with 5+ years of relevant post-graduate industry experience OR Master's degree in Chemistry, Biochemistry, Pharmaceutical Chemistry, or a related scientific discipline with 10+ years of relevant post-graduate industry experience.
Company overview
BioMarin Pharmaceutical Inc. is a leading global biotechnology company headquartered in San Rafael, California, specializing in the development and commercialization of innovative therapies for rare genetic diseases. Founded in 1997, the company has established itself as a pioneer in enzyme replacement therapies (ERTs) and genetic medicine, with a focus on addressing the root causes of serious, life-threatening conditions primarily affecting children. BioMarin's portfolio includes eight commercial therapies targeting various rare disorders, including mucopolysaccharidosis, phenylketonuria (PKU), achondroplasia, and hemophilia A. The company's groundbreaking work includes being the first to provide therapeutics for mucopolysaccharidosis type I and phenylketonuria. With approximately 3,000-3,500 employees worldwide and operations across North America, Europe, Asia Pacific, and South America, BioMarin maintains a strong commitment to transforming lives through genetic discovery. The company's research and development efforts continue to advance a robust pipeline of product candidates, applying a science-driven, patient-forward approach to address broader groups of genetic disorders.